๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2843568 1.33 M AR 06/02/2025 PNC20
PFIZER\WYETH
LX443
Injection site swelling Injection site swelling
leg swelling at the injection site with redness and warmth. Mom used benadryl cream and ice over the... leg swelling at the injection site with redness and warmth. Mom used benadryl cream and ice over the course of 2 days More
2843569 65 F 06/02/2025 PNC21
PNC21
PNC21
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
Z005765
Z005765
Z005765
Asthenia, Blood sodium decreased, Chest X-ray normal, Computerised tomogram neck... Asthenia, Blood sodium decreased, Chest X-ray normal, Computerised tomogram neck, Full blood count normal; Headache, International normalised ratio normal, Metabolic function test normal, Mobility decreased, Nausea; Pain in extremity, Prothrombin time normal, Troponin normal, Urine analysis normal, Vomiting More
Sore arm started evening of the vaccine that progressively worsened over time. Around midnight on M... Sore arm started evening of the vaccine that progressively worsened over time. Around midnight on May 25, patient reports weakness and the inability to get out of bed to go to the bathroom. The headache was described as the worst headache ever experienced. Patient had nausea and vomiting and generalized weakness. Patient admitted to ED around 8am. Patient administered ketorolac IV one dose along with diphenhydramine which helped with headache. Patient was discharged around noon. Patient's headache was gone the next day but after a week from this incidence she still reports fatigue. More
2843570 12 F OH 06/02/2025 HPV9
MERCK & CO. INC.
X019196
Expired product administered Expired product administered
The Medical Assistant assigned to the provider accidentally administered an expired vaccine to a pat... The Medical Assistant assigned to the provider accidentally administered an expired vaccine to a patient. The vaccine is ineffective, and the patient needs to get another dose of the medication. More
2843571 13 F WI 06/02/2025 HEP
MMRV
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
95BJ9
Y012077
No adverse event; No adverse event No adverse event; No adverse event
ProQuad vaccine was administered to patient on 05/30/2025. Patient is 13 years old, and ProQuad is n... ProQuad vaccine was administered to patient on 05/30/2025. Patient is 13 years old, and ProQuad is not routinely recommended for this age group. No adverse reaction observed at the time. Patient will be monitored as appropriate. Provider has been informed. More
2843572 41 F 06/02/2025 HPV9
MMR
TDAP
MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
Y018389
4N222
EB499
Chills, Pain, Pain in extremity, Pyrexia; Chills, Pain, Pain in extremity, Pyrex... Chills, Pain, Pain in extremity, Pyrexia; Chills, Pain, Pain in extremity, Pyrexia; Chills, Pain, Pain in extremity, Pyrexia More
Patient called on 6/2/25 to report allergic reaction that began evening of 6/1/25 after receiving va... Patient called on 6/2/25 to report allergic reaction that began evening of 6/1/25 after receiving vaccines. Patient described fever, body ache, chills, sore arm. Patient states that fever has resolved at this time but body soreness is still present. More
2843573 53 F MI 06/02/2025 HEP
DYNAVAX TECHNOLOGIES CORPORATION
945663
Inappropriate schedule of product administration Inappropriate schedule of product administration
Patient received 2nd dose only 2 weeks after first dose. @nd dose invalid due to be given too soon.... Patient received 2nd dose only 2 weeks after first dose. @nd dose invalid due to be given too soon. Patient only stated they felt tired no other reaction noted. More
2843574 8 M PA 06/02/2025 DTAPIPV
SANOFI PASTEUR
U8009AB
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Administered combo vaccine to an 8-year-old patient that is only indicated for ages 4-6, so he shoul... Administered combo vaccine to an 8-year-old patient that is only indicated for ages 4-6, so he should have received DTaP and IPV as separate injections. No adverse events or side effects reported by patient or his parents. Steps have been taken within the office to avoid this error in the future. More
2843575 1 M WI 06/02/2025 HEPA
MERCK & CO. INC.
X026666
Expired product administered Expired product administered
expired vaccines was administered to patient. vaccine expired on 5/29/2025 expired vaccines was administered to patient. vaccine expired on 5/29/2025
2843576 0.92 F MO 06/02/2025 MMR
MMR
MMR
MMR
MMR
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
Y 014095
Y 014095
Y 014095
Y 014095
Y 014095
Adenoidal hypertrophy, Blood culture negative, Body temperature increased, CSF c... Adenoidal hypertrophy, Blood culture negative, Body temperature increased, CSF culture negative, Clonus; Computerised tomogram head normal, Coronavirus test positive, Culture urine negative, Electroencephalogram normal, Endotracheal intubation; Gaze palsy, HCoV-HKU1 infection, Intensive care, Lethargy, Magnetic resonance imaging head normal; Mastoid effusion, Muscle twitching, Pharyngeal disorder, Respiratory viral panel, Seizure; Tonsillar hypertrophy More
On 4/27/25, patient and her mom were on a plane in (redacted state) about to return to (redacted sta... On 4/27/25, patient and her mom were on a plane in (redacted state) about to return to (redacted state). Mom noticed patient suddenly became lethargic with rightward gaze deviation, clonic movement of R arm, which spread to involve her full body. EMS gave two doses Versed with cessation of seizure for total duration of 20 minutes. She had a temp of 101.7F at that time. At Hospital, had L arm clonic movement, leftward gaze and intermittent twitching. Received two doses of IV lorazepam and Keppra bolus, was intubated and started on Versed drip. She was transferred to another level of care Hospital and admitted to the PICU. Started on Keppra, had continuous video EGG without seizure activity. She remained intubated for brain MRI, which was reassuring, then extubated and weaned to room air. Transitioned from Keppra to Klonopin by discharge. Received IV ceftriaxone, vancomycin and acyclovir while blood, urine and CSF studies were pending. She had mostly returned to baseline neurologic status by discharge on 4/30/25. She has since followed up with Pediatric Neurology on 5/12/25. She had an EEG on 5/7/25 that was normal for her age. More
โœ“ โœ“
2843577 54 F MN 06/02/2025 UNK
UNKNOWN MANUFACTURER

No adverse event No adverse event
No Adverse effects from employee. No Adverse effects from employee.
2843578 1.67 M CO 06/02/2025 HIBV
SANOFI PASTEUR
UK169AB
Product preparation error Product preparation error
When the Medical Assistant mixed the vaccine, the wrong sterile diluent was used. When the Medical Assistant mixed the vaccine, the wrong sterile diluent was used.
2843579 4 M AS 06/02/2025 DTAPIPV
UNK
SANOFI PASTEUR
UNKNOWN MANUFACTURER
u8209cb
Z007210
Urticaria; Urticaria Urticaria; Urticaria
URTICARIA DEVELOPED WITHIN ONE HOURPOST VACCINATION WITH MMRV AND QUADRACEEL. NO ANAPHYLACTIC SYMPTO... URTICARIA DEVELOPED WITHIN ONE HOURPOST VACCINATION WITH MMRV AND QUADRACEEL. NO ANAPHYLACTIC SYMPTOMS. TREATED WITH BENADRYL AND CETRIZINE.RESOLVED WITHIN 24 HOURS More
2843580 12 M ID 06/02/2025 MNQ
SANOFI PASTEUR
U8361AA
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
Patient was given second dose of Menquadfi too early. No adverse reactions reported. Patient was given second dose of Menquadfi too early. No adverse reactions reported.
2843581 60 F PA 06/02/2025 PNC21
TDAP
MERCK & CO. INC.
SANOFI PASTEUR
Y019158

Injection site bruising, Injection site swelling, Injection site warmth; Injecti... Injection site bruising, Injection site swelling, Injection site warmth; Injection site bruising, Injection site swelling, Injection site warmth More
Red to purple bruising 6"x4" in diameter on LEFT upper arm, as described by patient. Area... Red to purple bruising 6"x4" in diameter on LEFT upper arm, as described by patient. Area swollen and continues to be warm to touch. More
2843582 2 M ID 06/02/2025 DTAP
GLAXOSMITHKLINE BIOLOGICALS
GG39D
Extra dose administered Extra dose administered
I gave a DTaP thinking it was his 4th dose of DTaP; however, it was his 5th dose of DTaP upon furthe... I gave a DTaP thinking it was his 4th dose of DTaP; however, it was his 5th dose of DTaP upon further determination through another source. More
2843583 66 F MO 06/02/2025 PNC21
PNC21
MERCK & CO. INC.
MERCK & CO. INC.
Y019158
Y019158
Arthralgia, Immediate post-injection reaction, Injected limb mobility decreased,... Arthralgia, Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Loss of personal independence in daily activities; Musculoskeletal stiffness More
Patient had injection site pain immediately following administration as she normally does after immu... Patient had injection site pain immediately following administration as she normally does after immunizations, however 2-3 hours following administration the pain began to spread to her shoulder and create stiffness. It kept getting worse for 1-2 weeks, but then stopped getting worse and has been a constant and stable pain for about three weeks. She still cannot move her arm above her shoulder. She reached out to her PCP a couple weeks ago and his office told her to make an appointment if it did not improve. She said she has not had time to make an appointment and can't miss any more work for additional doctor's appointments. She said it does still impact her daily activity, but does not interfere with sleep (aside from it being more difficult to get out of bed). More
2843584 6 F 06/02/2025 IPV
VARCEL
SANOFI PASTEUR
MERCK & CO. INC.


No adverse event, Wrong patient; No adverse event, Wrong patient No adverse event, Wrong patient; No adverse event, Wrong patient
No adverse event occurred, this event was a medication/vaccine error. The pt was ordered to have Hep... No adverse event occurred, this event was a medication/vaccine error. The pt was ordered to have Hep B and MMR but was given Varicella and Polio (ordered for sister present at time of visit). Both siblings were in the exam room. More
2843585 27 M MI 06/02/2025 ANTH
ANTH
EMERGENT BIOSOLUTIONS
EMERGENT BIOSOLUTIONS


Condition aggravated, Cough, Ear infection, Encephalitis, Hypersensitivity; Mali... Condition aggravated, Cough, Ear infection, Encephalitis, Hypersensitivity; Malignant melanoma, Tinnitus, Upper-airway cough syndrome More
Melanoma with unknown primary, encephalitis of the brain, various allergies, post nasal drip with co... Melanoma with unknown primary, encephalitis of the brain, various allergies, post nasal drip with cough, tinnitus, ear infections. More
โœ“ โœ“ โœ“
2843586 31 F NV 06/02/2025 COVID19
MODERNA
B0005
Malaise Malaise
States felt "unwell" day of vaccination. No other symptoms indicated. States felt "unwell" day of vaccination. No other symptoms indicated.
2843587 18 F NM 06/02/2025 MNQ
SANOFI PASTEUR
U799688
No adverse event, Wrong product administered No adverse event, Wrong product administered
the child did not have any adverse reactions to the medication, after she had left the clinic is whe... the child did not have any adverse reactions to the medication, after she had left the clinic is when I realized that I had given the wrong meningococcal vaccine for the wrong age. More
2843588 47 F MA 06/02/2025 PNC21
PNC21
MERCK & CO. INC.
MERCK & CO. INC.


Chills, Fatigue, Influenza like illness, Injection site erythema, Lymphadenopath... Chills, Fatigue, Influenza like illness, Injection site erythema, Lymphadenopathy; Myalgia, Pain in extremity, Pyrexia, Throat irritation, Upper-airway cough syndrome More
I received the CAPVAXIVE (21-valent pneumococcal conjugate) vaccine on Saturday, May 31st around 3:0... I received the CAPVAXIVE (21-valent pneumococcal conjugate) vaccine on Saturday, May 31st around 3:00 PM at a pharmacy. The vaccine was administered as part of an immunological workup due to suspected immune dysfunction (possible CVID or MCAS), to evaluate my ability to mount an appropriate antibody response. Within 24 hours, I developed significant arm pain and redness at the injection site, which progressively worsened rather than improved. By 36?48 hours post-injection, the pain had intensified and spread from the deltoid area down into the lower bicep, with visible redness and swelling. I also experienced chills, deep fatigue, and flu-like symptoms, leading me to go to bed at 4:45 PM the following day. As of today (just under 48 hours post-vaccine), I continue to have significant fatigue, a low-grade fever, mild throat irritation, postnasal drip, and swollen lymph nodes? all localized to the left side only, corresponding with the arm where the vaccine was administered. The red area on my arm is about the size of a palm. For symptom management, I?ve used Zyrtec (cetirizine), famotidine, as well as Advil (ibuprofen) every 4?6 hours. This combination makes it possible to lift my arm, but the pain returns between doses. I plan to go to bed early again due to ongoing fatigue. No formal medical evaluation yet. Symptoms are still active at the time of this report. More
2843590 21 F NV 06/02/2025 COVID19
MODERNA
B0005
Unevaluable event Unevaluable event
None known None known
2843591 9 F ID 06/02/2025 HEP
TD
VARCEL
MERCK & CO. INC.
SANOFI PASTEUR
MERCK & CO. INC.
X004819
U7745AA
X018954
Extra dose administered; Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered; Extra dose administered
I misunderstood that patient needed a 3rd Tetanus, due to no childhood doses and had only 2 tetanus ... I misunderstood that patient needed a 3rd Tetanus, due to no childhood doses and had only 2 tetanus at that point. It was discussed with father at the time - because database indicated complete. He agreed to get 3rd dose for child. More
2843592 66 F NM 06/02/2025 MMR
MERCK & CO. INC.
NDC: 00006-4681
Abdominal pain, Arthralgia, Decreased appetite, Fatigue, Nausea Abdominal pain, Arthralgia, Decreased appetite, Fatigue, Nausea
Six days after shot began extreme fatigue. It has continued. Days 7 to 10 systemic joint pain. I tri... Six days after shot began extreme fatigue. It has continued. Days 7 to 10 systemic joint pain. I tried 2 days of Aleve but it didn't help as much as the advil I took today. Days 8 to 10 abdominal pain, nausea, and low appetite. More
2843593 0.5 M TX 06/02/2025 FLU3
HEPA
PNC20
RV5
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
MERCK & CO. INC.
ut8459ja
c24b9
hr3650
y003996
Product administered to patient of inappropriate age; Product administered to pa... Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age More
Given Havrix instead of Vaxelis. Not old enough for Vaxelis. Given Havrix instead of Vaxelis. Not old enough for Vaxelis.
2843594 14 M TN 06/02/2025 MMRV
MERCK & CO. INC.
Y017514
Extra dose administered, No adverse event Extra dose administered, No adverse event
RN administered the Varivax vaccine and ProQuad vaccine on the same day. RN thought that she was adm... RN administered the Varivax vaccine and ProQuad vaccine on the same day. RN thought that she was administering MMR instead of ProQuad, but administered ProQuad (MMRV) and Varivax together. RN spoke to MD after the event around 11:15. RN notified the pt and the pt guardian that the pt received 2 doses of Varicella. Pt was monitored for 20 min after the event. No adverse outcomes were noted. RN gave pt strict return to clinic / ED protocol if pt develops a rash, fever > 101 F, difficulty breathing, facial swelling, or other concerning symptoms. More
2843595 62 M AZ 06/02/2025 PNC20
VARZOS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
LN4927
47N34
Rash; Rash Rash; Rash
On May 7, 2025, pt received Prevnar 20 and Shingrix vaccines. On June 2, 2025, pt came to the pharma... On May 7, 2025, pt received Prevnar 20 and Shingrix vaccines. On June 2, 2025, pt came to the pharmacy to report a rash that he developed 4 days after receiving the vaccines. Pt has been only using a moisturizer cream to help with the rash. Advised pt to take Zyrtec or Benadryl and use hydrocortisone cream 1% and if symptoms persist or worsen to seek medical help. Pt verbalized understanding. Pt did not report any allergies and states he is not taking any medications. More
2843596 1.92 F ID 06/02/2025 COVID19
PFIZER\BIONTECH
LN6739
Inappropriate schedule of product administration Inappropriate schedule of product administration
Dose 3 given 3 weeks after dose 2 instead of waiting the 8 weeks. Dose 3 given 3 weeks after dose 2 instead of waiting the 8 weeks.
2843597 4 M CA 06/02/2025 DTAP
SANOFI PASTEUR
3CA20C1
Erythema, Peripheral swelling, Pruritus, Skin warm Erythema, Peripheral swelling, Pruritus, Skin warm
Per mom after patient recived vaccine, patients arm began to swell up. The next day mom notice patie... Per mom after patient recived vaccine, patients arm began to swell up. The next day mom notice patient's arm got red and itchy and the arm felt warm. Mom had been giving Motrin for pain and it looked to be helping patient per mom. More
2843606 45 F 06/02/2025 PNC20
PFIZER\WYETH

Dermatitis, Injection site erythema, Injection site pain, Vasculitis Dermatitis, Injection site erythema, Injection site pain, Vasculitis
Development of pain and redness at injection site; Development of pain and redness at injection site... Development of pain and redness at injection site; Development of pain and redness at injection site; Development of vasculitis/dermatitis on both legs; Development of vasculitis/dermatitis on both legs; This is a spontaneous report received from a Consumer or other non HCP. A 45-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 20May2025 as dose number unknown, single (Batch/Lot number: unknown) at the age of 45 years, in left arm for immunisation. The patient's relevant medical history included: "Lupus SLE" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Allergy to shellfish" (unspecified if ongoing). Concomitant medication(s) included: PREDNISONE, start date: 14May2025; COLCHICINE, start date: 12Feb2025. The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 22May2025, outcome "recovering" and all described as "Development of pain and redness at injection site"; DERMATITIS (non-serious), VASCULITIS (non-serious) all with onset 22May2025, outcome "recovering" and all described as "Development of vasculitis/dermatitis on both legs". Therapeutic measures were taken as a result of dermatitis, vasculitis including the use of steroid ointment for legs. Additional information: Development of pain and redness at injection site that persists over 1 week. Development of vasculitis/dermatitis on both legs 2 days after administration. The patient did not receive any other vaccines on the same date as the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2843607 41 F TX 06/02/2025 COVID19
PFIZER\BIONTECH

Vaginal haemorrhage Vaginal haemorrhage
After the first vaccination she had the vaginal bleeding/ vaginal bleeding for the two years; This i... After the first vaccination she had the vaginal bleeding/ vaginal bleeding for the two years; This is a spontaneous report received from a Consumer or other non HCP. A 41-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) at the age of 41 years, in arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VAGINAL HAEMORRHAGE (medically significant), outcome "not recovered", described as "After the first vaccination she had the vaginal bleeding/ vaginal bleeding for the two years". The event "after the first vaccination she had the vaginal bleeding/ vaginal bleeding for the two years" required physician office visit. Patient mentioned route of administration as: arm, unknown if left or right side. Other Conditions/ products mentioned as No; Investigations mentioned as: No. Calling about Covid Vaccination, Pfizer Covid Vaccination. The patient received the vaccine 2 years ago. Patient also been bleeding since got the vaccination. She has been having vaginal bleeding for the two years. Have been seen by several specialist not just one. When attempted to clarify if there was a specific one to provide she stated her primary doctor she just moved. Other Conditions: At the time took the vaccination was a very health woman. Was not taking any medications. The patient did not receive any other vaccines on the same date as the Pfizer vaccine. The patient did not receive any other vaccines within 4 weeks prior to the first administration of the suspect vaccine. Confirmed had the bleeding with the first vaccination. After the first vaccination she had the vaginal bleeding, but she was not aware why she was going through it. The patient was not allergic to any previous vaccination, medications, food or other products. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500111472 same patient, reporter, vaccine/ different dose/event; More
2843608 F MO 06/02/2025 COVID19
UNKNOWN MANUFACTURER

COVID-19, Drug ineffective, SARS-CoV-2 test COVID-19, Drug ineffective, SARS-CoV-2 test
had covid; had covid; This is a spontaneous report received from a Consumer or other non HCP. A fem... had covid; had covid; This is a spontaneous report received from a Consumer or other non HCP. A female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "had covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2843610 F 06/02/2025 COVID19
PFIZER\BIONTECH

COVID-19, Drug ineffective COVID-19, Drug ineffective
has long Covid symptoms; has long Covid symptoms; This is a spontaneous report received from a Consu... has long Covid symptoms; has long Covid symptoms; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): NOV25-00368 (Novavax). A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "has long Covid symptoms". Clinical course: Reporter stated she was trying to find a Novavax vaccine for her daughter before she was travelling to (redacted). She stated her daughter "needs to get the Novavax because she reacted very badly to Pfizer and everything". She did not mention if daughter has had any Novavax Covid-19 vaccine previously. She also stated that her daughter "has long Covid symptoms and can't have the other two vaccines. No follow-up attempts are possible. Batch/Lot number is not provided, and it cannot be obtained More
2843611 9 F MA 06/02/2025 DTAPIPVHIB
SANOFI PASTEUR
UJ807AA
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
inappropriate use due to administering Pentacel when the same patient was 7 and 9 years old with no ... inappropriate use due to administering Pentacel when the same patient was 7 and 9 years old with no reported adverse event; Initial information received on 30-May-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 years old female patient who was inappropriately use administered with Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] when the patient was 7 and 9 years old with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Hepatitis a vaccine (Hepatitis a vaccine) and Varicella zoster vaccine live (Oka/Merck) (Varivax) for Immunisation. On 24-Feb-2025, the patient received 0.5mL (dose 1) of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine, Suspension for injection ((lot UK168AA, expiry date 31-Oct-2025) via intramuscular route in the deltoid NOS (not other specified) and on 11-Apr-2023 she also received 0.5mL (dose 2) of vaccine (lot UJ807AA, expiry date 01-Oct-2023) (frequency once and strength standard) via intramuscular route in the deltoid NOS for Immunisation. On 24-Feb-2025, the patient was inappropriately administered with pentacel when the same patient was 7 and 9 years old with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Reportedly, the reporter called to ask a question regarding the administration of Pentacel. She mentioned that the patient came from another country and she was behind her routine vaccines. Patient needed DTAP, IPV, and HIB. Pentacel was first given when the patient was 7 years old and now that she's 9 years old. Reporter asked if it was okay or if the patient needs to be re-vaccinated. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2843612 4 M ID 06/02/2025 MMRV
MERCK & CO. INC.
Y008284
Inappropriate schedule of product administration Inappropriate schedule of product administration
Proquad given within 28 days after Flumist vaccine Proquad given within 28 days after Flumist vaccine
2843613 32 M MN 06/02/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
MZ474
Underdose Underdose
PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION
2843614 71 F 06/02/2025 TDAP
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PG3RP
9L944
Blister, Fatigue, Vomiting; Blister, Fatigue, Vomiting Blister, Fatigue, Vomiting; Blister, Fatigue, Vomiting
Patient states that the evening of her vaccinations, she experienced vomiting that lasted for severa... Patient states that the evening of her vaccinations, she experienced vomiting that lasted for several days, in addition to fatigue and blisters on her scalp. She indicated that these symptoms persisted for one week following vaccinations. More
2843615 34 M MN 06/02/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
1Z474
Underdose Underdose
PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITS A VACCINATION PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITS A VACCINATION
2843616 57 M MN 06/02/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
MZ474
Underdose Underdose
PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION
2843617 65 M MN 06/02/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
MZ474
Underdose Underdose
PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION
2843618 55 F MN 06/02/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
mz474
Underdose Underdose
PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION PATIENT WAS GIVEN PEDIATRIC DOSE AS OPPOSED TO ADULT DOSE OF HEPATITIS A VACCINATION
2843619 65 F FL 06/02/2025 RSV
PFIZER\WYETH
LN4P2
Arthralgia, Mobility decreased, Pain in extremity Arthralgia, Mobility decreased, Pain in extremity
arm pain, patient claims she can not lift arm or stretch arm out with pain, joint pain arm pain, patient claims she can not lift arm or stretch arm out with pain, joint pain
2843620 55 F CO 06/02/2025 JEV1
TYP
INTERCELL AG
SANOFI PASTEUR
jev23ko7e
y2a021m
Dizziness, Gait disturbance, Hypoaesthesia, Nausea, Vomiting; Dizziness, Gait di... Dizziness, Gait disturbance, Hypoaesthesia, Nausea, Vomiting; Dizziness, Gait disturbance, Hypoaesthesia, Nausea, Vomiting More
on 5-30-25 the patient contacted her doctor and stated that she had nausea and vomiting and dizzines... on 5-30-25 the patient contacted her doctor and stated that she had nausea and vomiting and dizziness. Her right arm, leg, and foot felt numb and she felt like her foot was slapping when she walked. She reported to the doctor that she was better on 6-2-25 More
2843626 50 F NV 06/02/2025 VARZOS
VARZOS
VARZOS
VARZOS
VARZOS
VARZOS
VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
unknown
unknown
unknown
unknown
5y4tl
5y4tl
5y4tl
5y4tl
Chills, Injection site cellulitis, Injection site erythema, Injection site pain,... Chills, Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling; Injection site warmth, Nausea, Pyrexia, Rash; Cellulitis, Chills, Influenza like illness, Injection site erythema, Pain; Pyrexia; Chills, Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling; Injection site warmth, Nausea, Pyrexia, Rash; Cellulitis, Chills, Influenza like illness, Injection site erythema, Pain; Pyrexia More
Cellulitus at injection site diagnosed by PCP requiring antibiotics and steroid. Belly rash after 48... Cellulitus at injection site diagnosed by PCP requiring antibiotics and steroid. Belly rash after 48 hours. Prednisone and Clindamycin prescribed. Sore injection site within hours of injection. Fever, chills, nausea began 12 hours after injection and lasted 48 hours. 24 hours after injection, injection site was red(1"), swollen, hot, painful. Redness was approximately 1". By hour 48, redness was 2". By hour 72, redness was 3". Saw my PCP at hour 72 and he said it is infected and prescribed me antibiotics and steroids. More
2843627 60 F FL 06/02/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
93kk4
Peripheral swelling, Skin reaction, Tenderness Peripheral swelling, Skin reaction, Tenderness
Pt showed up to pharmacy with large read , swollen area on left arm. tender to the touch Pt showed up to pharmacy with large read , swollen area on left arm. tender to the touch
2843628 57 F NM 06/02/2025 PNC20
VARZOS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
LW1951
445TK
Blister, Rash pruritic; Blister, Rash pruritic Blister, Rash pruritic; Blister, Rash pruritic
Full body itchy rash with small blisters, started 11 days after vaccination and lasted for several w... Full body itchy rash with small blisters, started 11 days after vaccination and lasted for several weeks. Did not require treatment. More
2843629 50 F CA 06/02/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
75D3A
Arthralgia, Mobility decreased Arthralgia, Mobility decreased
ON 05-23-25, SHINGRIX VACCINE WAS ADMINISTERED BY RPH. PT HAD CONTACTED RPH: IN REGARDS TO HER CONCE... ON 05-23-25, SHINGRIX VACCINE WAS ADMINISTERED BY RPH. PT HAD CONTACTED RPH: IN REGARDS TO HER CONCERN OF EXPERIENCING PAIN ALONG LEFT SHOULDER JOINT AREA, AND THE INABILITY TO LIFT HER LEFT ARM ON 5-23-25 AROUND 5:45 PM. RPH HAD ADVISED HER MAY BE POSSIBLE SIDE EFFECT OF MUSCLE TENDERNESS AT INJECTION SITE, AND TO APPLY A COLD COMPRESS AND TAKE OTC IBUPROFEN IF TOLERATED. RPH, HAD ADVISED PT IF PAIN BECOMES SEVERE TO IMMEDIATELY CONTACT HER MD AND SEEK MEDICAL ATTENTION. ON 5-24-25, PT WAS PRESCRIBED MEDROL DOSE PACK BY HER NP. PRESCRIBER BELIEVES THAT VACCINE WAS ADMINISTERED TOO HIGH UP THE SHOULDER REGION IN THE SHOULDER CAPSULE CAUSING HER CHRONIC PAIN, LIMITED SHOULDER MOVEMENT, AND NERVE PAIN. PT HAS BEEN IN CHRONIC PAIN, AND WAS UNABLE TO SIGNIFICANTLY MOVE HER LEFT ARM FROM 5-23-25 TO 5-28-25. ON 5-28-25, PT WAS ALSO COMPLAINING OF SHARP PAIN RADIATING DOWN HER LEFT ARM. AS OF 6-2-25, PT INDICATED SHE IS ABLE TO MOVE HER SHOULDER, AND PAIN HAS SUBSIDED BUT NOT COMPLETELY. HOWEVER, SHE IS NOT ABLE TO PLACE ANY RESISTANCE (WEIGHT) ALONG THE LEFT ARM/ SHOULD REGION. SHOULDER IS STILL SORE. More
2843630 21 F OR 06/02/2025 TYP
BERNA BIOTECH, LTD.
US-VIV 2300013
Blood test, Dyspnoea, Hypersensitivity, Paraesthesia oral, Pharyngeal paraesthes... Blood test, Dyspnoea, Hypersensitivity, Paraesthesia oral, Pharyngeal paraesthesia More
Severe allergic reaction, onset approximately 5-7 minutes following ingestion of the oral capsule. S... Severe allergic reaction, onset approximately 5-7 minutes following ingestion of the oral capsule. Symptoms began with tingling in the mouth/throat, and quickly progress to difficulties breathing within a minute. EpiPen was administered quickly, less than 5 minutes after the reaction started. Patient was conscious and showing minimal symptoms when ambulance arrived. Patient was transferred a local ER, and was given intravenous methylprednisone, diphenhydramine, and fomatidine. Patient was monitored for approximately 4 hours, and no further events or complications occurred. Patient was sent home with a 5-day course of prednisone, and instructions to take OTC Benadryl as needed for at least 5 days. More
2843631 59 M OR 06/02/2025 PNC21
MERCK & CO. INC.

Fatigue Fatigue
Excessive fatigue Excessive fatigue
2843632 79 M CA 06/02/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS

Acne, Chest discomfort, Herpes zoster Acne, Chest discomfort, Herpes zoster
Had 2 dots of Shingles awhile back in Feb./Mar. 2025 after taking Zoster vaccine many years ago. Dr... Had 2 dots of Shingles awhile back in Feb./Mar. 2025 after taking Zoster vaccine many years ago. Dr. suggested getting a 3rd shot and when I went to pharmacy, they said I never had Shingrix and should get 2 shots, 2nd after 2-6 months. About 2 weeks after getting shot I felt that same pimple/dot on my chest that I had Shingles back in Feb.Mar. and it feels the same discomfort. It is still there and uncomfortable, but 2nd dot has not turned up as yet. This seems like it should not happen and when researching on internet was directed to submit this adverse reaction but getting Shingles in same spot 2nd time after taking dose 1 of Shingrix More